Kritzer MD

Depression Clinical and Research Program, Psychiatry Department, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.

2 papers · ORCID

ArticleKetamine

Changes in depression symptom network structure following ketamine treatment in treatment-resistant depression.

Curtiss J, Dasari L, Origlio J +12

Europe PMC2026
ArticleKetamine

Key considerations for the use of ketamine and esketamine for the treatment of depression: focusing on administration, safety, and tolerability.

Kritzer MD, Pae CU, Masand PS

Europe PMC2022